Colgate-Palmolive assumed with a Neutral at Piper Sandler

Piper Sandler assumed coverage of Colgate-Palmolive (CL) with a Neutral rating and $84 price target The company has strong brands and brand equity along with a “compelling footprint,” particularly in Latin America, the analyst tells investors in a research note. However, Piper believes Colgate’s category headwinds will likely to persist in the near-term.